Publications
Specialty
Search
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular, EP Lab Digest
10/28/2024
The pivotal investigational device exemption (IDE) study, which enrolled 256 patients at 18 sites in the US, met the primary endpoint. MACCE (Major Adverse Cardiac and Cerebrovascular Events) rate at 30 days was 6.3%, significantly below the pre-defined performance goal (see figure 1).
Vascular Disease Management, CardioVascular, Journal of Invasive Cardiology
10/28/2024
First-of-its-kind Dual-Drug Therapy for Coronary De Novo Disease Moves Toward U.S. Clinical Phase
Podiatry Today, Podiatry
10/28/2024
Podiatry Today spoke to Nicholas R. Butler, DPM, AACFAS, FACPM, FASPS, about his ASPS presentation on the evolution of the Lapidus arthrodesis.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
10/28/2024
The investigators shared the first randomized controlled trial (RCT) of FFRangio outcomes compared to invasive wire-based fractional flow reserve (FFR) has met its primary endpoint and revealed significant economic and resource utilization advantages for the non-invasive FFRangio technology over traditional wire-based approaches.
Psych Congress Network
10/28/2024
Christoph Correll, MD, offers clinical guidance for managing adverse affects from schizophrenia treatment, including weight gain and movement disorder
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
10/28/2024
The Armery solution maximizes support and protection during radial procedures, and furthers Rampart’s mission to provide radiation protection solutions for healthcare teams delivering care in interventional suites.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
10/27/2024
The A-FLUX Reducer System is engineered with SwiftCell Technology™, a small-cell proprietary design based on computational modeling, to redistribute oxygen supply to the sub-endocardium layer of the heart muscle.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
10/27/2024
The SirPlux Duo DCB is designed to deliver sirolimus and paclitaxel simultaneously to inhibit cell growth at a higher potency and efficient dose.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
10/27/2024
The Adona device includes a shunt that features a flow channel with an adjustable geometry that can be made larger or smaller post-implantation via the use of a proprietary induction catheter.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
10/27/2024
HeartFlow News
Journal of Clinical Pathways
10/25/2024
A systematic review and meta-analysis found a significant association between hypertension and an increased risk of endometrial cancer.
Lymphoma, Leukemia & Myeloma Network, Oncology
10/25/2024
At the 2024 Lymphoma, Leukemia & Myeloma Congress, Bruno Paiva, PhD, shared expert insight into the immune determinants of response and resistance among patients with multiple myeloma, highlighting the need to bring immune biomarkers into the clinic.
Journal of Clinical Pathways
10/25/2024
Learn about recent advancements in CLL treatment including the potential approval of new combination therapies and the evolving landscape of targeted therapies.
EP Lab Digest
10/25/2024
Medtronic Press Release
GALWAY, Ireland, Oct. 24, 2024 -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced United States Food and Drug Administration (FDA) approval of the Affera™ Mapping and Ablation System with Sphere-9™ Catheter, an all-in-one, high-density (HD) mapping and pulsed field (PF) and radiofrequency (RF) ablation catheter for treatment of persistent atrial fibrillation (AFib) and for RF ablation of cavotricuspid isthmus (CTI) dependent atrial flutter.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
10/25/2024
With this decision, five of the seven Medicare Administrative Contractors (MACs) will soon provide coverage for AI-enabled quantitative coronary plaque analysis, expanding accessibility to over 70 percent of eligible Medicare patients across the United States.
First Report Managed Care
10/25/2024
Recent advancements in the treatment of pulmonary arterial hypertension have shifted clinical practices toward combination therapies, particularly highlighting the role of riociguat.
Cath Lab Digest, Journal of Invasive Cardiology, Vascular Disease Management, CardioVascular
10/25/2024
“The unique maneuverability of the large-bore Vertex endoportal device enabled us to easily navigate across multiple bends through the right heart and into the pulmonary arteries," said Mitchell Weinberg, MD.
Advances in Inflammatory Bowel Disease Network
10/25/2024
Dr Ashburn explains the surgical techniques that can help relieve pain and promote healing for patients with perianal and fistulizing Crohn's disease.
Journal of Clinical Pathways
10/25/2024
Abemaciclib, a CDK4/6 inhibitor used in breast cancer treatment, shows promise in targeting novel mechanisms in endometrial cancer for potential therapeutic benefits in cases of recurrence, particularly in estrogen receptor-positive patients.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
10/25/2024
The latest Evolut FX+ TAVI system offers three larger coronary access windows through a modified diamond-shaped frame design, which are four times larger than regular cells of the Evolut TAVI system.